Medtronic Inc
(MDT)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 04/30
| 10-2020 | 07-2020 | 04-2020 | 01-2020 | 10-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 985,000 | 491,000 | 4,806,000 | 4,167,000 | 2,248,000 |
| Depreciation Amortization | 1,340,000 | 669,000 | 2,663,000 | 1,991,000 | 1,328,000 |
| Income taxes - deferred | -69,000 | 3,000 | -1,315,000 | -793,000 | -245,000 |
| Accounts receivable | -669,000 | -142,000 | 1,291,000 | -119,000 | 39,000 |
| Other Working Capital | -833,000 | -1,060,000 | 61,000 | -429,000 | -692,000 |
| Other Operating Activity | 1,385,000 | 317,000 | -272,000 | 967,000 | 699,000 |
| Operating Cash Flow | $2,139,000 | $278,000 | $7,234,000 | $5,784,000 | $3,377,000 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -1,023,000 | 358,000 | -1,465,000 | -2,458,000 | -966,000 |
| PPE Investments | -615,000 | -334,000 | -1,213,000 | -877,000 | -584,000 |
| Net Acquisitions | -370,000 | N/A | -488,000 | -199,000 | -201,000 |
| Other Investing Activity | -4,000 | -16,000 | -37,000 | -34,000 | -16,000 |
| Investing Cash Flow | $-2,012,000 | $8,000 | $-3,203,000 | $-3,568,000 | $-1,767,000 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 2,732,000 | 2,773,000 | -17,000 | 17,000 | 42,000 |
| Debt Issued | 7,172,000 | N/A | 5,568,000 | 5,568,000 | 5,568,000 |
| Debt Repayment | -6,336,000 | -11,000 | -6,110,000 | -5,606,000 | -5,594,000 |
| Common Stock Issued | 119,000 | 26,000 | 662,000 | 585,000 | 432,000 |
| Common Stock Repurchased | -68,000 | N/A | -1,326,000 | -1,208,000 | -962,000 |
| Dividend Paid | -1,558,000 | -778,000 | -2,894,000 | -2,170,000 | -1,447,000 |
| Other Financing Activity | -70,000 | -51,000 | -81,000 | -74,000 | -54,000 |
| Financing Cash Flow | $1,991,000 | $1,959,000 | $-4,198,000 | $-2,888,000 | $-2,015,000 |
| Exchange Rate Effect | 162,000 | 114,000 | -86,000 | -12,000 | -26,000 |
| Beginning Cash Position | 4,140,000 | 4,140,000 | 4,393,000 | 4,393,000 | 4,393,000 |
| End Cash Position | 6,420,000 | 6,499,000 | 4,140,000 | 3,709,000 | 3,962,000 |
| Net Cash Flow | $2,280,000 | $2,359,000 | $-253,000 | $-684,000 | $-431,000 |
| Free Cash Flow | |||||
| Operating Cash Flow | 2,139,000 | 278,000 | 7,234,000 | 5,784,000 | 3,377,000 |
| Capital Expenditure | -615,000 | -334,000 | -1,213,000 | -877,000 | -584,000 |
| Free Cash Flow | 1,524,000 | -56,000 | 6,021,000 | 4,907,000 | 2,793,000 |